Cargando…
Bupivacaine inhibits a small conductance calcium‐activated potassium type 2 channel in human embryonic kidney 293 cells
BACKGROUND: Bupivacaine blocks many ion channels in the heart muscle, causing severe cardiotoxicity. Small-conductance calcium-activated potassium type 2 channels (SK2 channels) are widely distributed in the heart cells and are involved in relevant physiological functions. However, whether bupivacai...
Autores principales: | Chen, Hongfei, Jin, Zhousheng, Xia, Fangfang, Fu, Zhijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953788/ https://www.ncbi.nlm.nih.gov/pubmed/33712065 http://dx.doi.org/10.1186/s40360-021-00481-2 |
Ejemplares similares
-
Epinephrine reversed high-concentration bupivacaine- induced inhibition of calcium channels and transient outward potassium current channels, but not on sodium channel in ventricular myocytes of rats
por: Liu, Fuli, et al.
Publicado: (2015) -
Acepromazine inhibits hERG potassium ion channels expressed in human embryonic kidney 293 cells
por: Joo, Young Shin, et al.
Publicado: (2017) -
Dexmedetomidine may decrease the bupivacaine toxicity to heart
por: Jin, Zhousheng, et al.
Publicado: (2021) -
Cardiac small-conductance calcium-activated potassium channels in health and disease
por: Zhang, Xiao-Dong, et al.
Publicado: (2021) -
Dexmedetomidine enhances tolerance to bupivacaine cardiotoxicity in the isolated rat hearts: alpha 2 adrenoceptors were not involved
por: Xia, Fangfang, et al.
Publicado: (2019)